FDA Inspection 1131410 — EPIMRD D.B.A. Western Sky Medical Research
The FDA completed an inspection of EPIMRD D.B.A. Western Sky Medical Research on Aug 20, 2020 in El Paso, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 20, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- El Paso, TX (United States)
Additional details
Clinical BA/BE